Sodium orthovanadate ≥96%, Powder
Supplier: MP BIOMEDICALS (FKA ICN BIOMED
Inhibits ATPase, alkaline phosphatase and tyrosine phosphatase. Decavanadate, which is formed at acidic pH, inhibits inositol 1,4,5-trisphosphate (IP3)-induced Ca2+ release from endocrine cells and blocks IP3 binding to its receptor in brain tissue.
Sodium Orthovanadate is used in the diabetes study. Inhibits ATPase, alkaline phosphatase and tyrosine phosphatase. Decavanadate, which is formed at acidic pH, inhibits inositol 1,4,5-trisphosphate (IP3)-induced Ca2+ release from endocrine cells and blocks IP3 binding to its receptor in brain tissue.
Soluble in water (50 mg/mL- clear to hazy, colorless to faint yellow solution).
Sodium Orthovanadate is used in the diabetes study. Inhibits ATPase, alkaline phosphatase and tyrosine phosphatase. Decavanadate, which is formed at acidic pH, inhibits inositol 1,4,5-trisphosphate (IP3)-induced Ca2+ release from endocrine cells and blocks IP3 binding to its receptor in brain tissue.
Formula:
Na₃O₄V MW: 183.91 g/mol |
MDL Number:
MFCD00003511 CAS Number: 13721-39-6 |
Learn more

About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...